ArticleTransplant infectious disease : an official journal of the Transplantation Society

Kidney Transplant Recipients Develop Nasal Mucosal Antibodies to SARS-CoV-2 With ACE2-Inhibiting Activity Following mRNA Vaccination.

Vera J C H Koomen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.